Form 4 Filing for ANGIODYNAMICS INC

This filing details a transaction by Chad Thomas Campbell, SVP/GM of Vascular Access at ANGIODYNAMICS INC. On July 15, 2026, Mr. Campbell acquired 16,081 shares of common stock through the grant of restricted stock units and performance rights. The restricted stock units vest in four equal annual installments starting July 15, 2027. The performance rights are tied to total shareholder return over a three-year period, with a potential payout ranging from 0% to 240% of the target number of shares. These transactions were reported on a Form 4 filing. The acquisition of restricted stock units has a post-transaction ownership of 104,540 shares, while the performance rights result in 16,081 shares owned post-transaction.